COVID-19 Special Public Health Surveillance Bulletin

This report details the preliminary results of a COVID-19 healthcare utilisation and seroprevalence survey (HUTS study) from three communities in South Africa, and shows an overall SARS-CoV-2 seroprevalence of 35.8% as of end January 2021. This suggests a substantial increase in seroprevalence during the second COVID-19 wave – most likely as a consequence of the greater transmissibility of the 501Y.V2 variant.